1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Patrys Limited
  6. News
  7. Summary
    PAB   AU000000PAB9

PATRYS LIMITED

(PAB)
Delayed Australian Stock Exchange  -  02:10 2022-06-24 am EDT
0.0220 AUD   +10.00%
06/14Patrys Identifies New Mechanism of Action for Anti-Cancer Antibody
MT
06/03Patrys Secures Grant Funding to Develop Brain Cancer Drug
MT
04/27PATRYS : Appendix 4C - Quarterly - 31 March 2022
PU
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Patrys : Change of Director's Interest Notices x2

12/06/2021 | 03:42am EDT

Appendix 3Y Change of Director's Interest Notice

Appendix 3Y

Rule 3.19A.2

For personal use only

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity

Patrys Limited

ABN

97 123 055 363

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director

James Campbell

Date of last notice

19 November 2021

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest

Direct and Indirect

Nature of indirect interest

Barrabool Biotechnology Pty Ltd

(including registered holder)

Campbell Family A/C>

Note: Provide details of the circumstances giving rise to the relevant

interest.

Dr. Campbell is a beneficiary of the above

entity

Date of change

6 December 2021

  • See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1

For personal use only

Appendix 3Y

Change of Director's Interest Notice

No. of securities held prior to change

Direct:

16,045,961 Fully paid ordinary shares

3,283 PABO Listed options, exercisable at

$0.024 (2.4 cents), expiring 5 August 2023

335,522

PABOA

Listed

options,

exercisable at $0.04 (4 cents), expiring 15

December 2023

10,000,000

Unlisted

options,

exercisable

at $0.035, expiring on 22 November 2023

11,000,000 Unlisted options, exercisable at

$0.027 (2.7 cents), expiring on 18

December 2024

25,000,000

Unlisted

options,

exercisable

at $0.059 (5.9 cents), expiring on 30

September 2025

Indirect:

1,386,461 Fully paid ordinary shares

396,132 PABO Listed options, exercisable

at $0.024 (2.4 cents), expiring 5 August

2023

66,022 PABOA Listed options, exercisable

at $0.04 (4 cents), expiring 15 December

2023

Class

Fully paid ordinary shares

Number acquired

(1)

Direct:

1,337,164 Fully paid ordinary shares

(2)

Indirect:

115,539 Fully paid ordinary shares

Number disposed

-

Value/Consideration

(1)

$46,800.74

Note: If consideration is non-cash, provide details and estimated

(2)

$4,043.87

valuation

+ See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

For personal use only

Appendix 3Y

Change of Director's Interest Notice

No. of securities held after change

Direct:

17,383,125 Fully paid ordinary shares

3,283 PABO Listed options, exercisable at

$0.024 (2.4 cents), expiring 5 August 2023

335,522

PABOA

Listed

options,

exercisable at $0.04 (4 cents), expiring 15

December 2023

10,000,000

Unlisted

options,

exercisable

at $0.035, expiring on 22 November 2023

11,000,000 Unlisted options, exercisable at

$0.027 (2.7 cents), expiring on 18

December 2024

25,000,000

Unlisted

options,

exercisable

at $0.059 (5.9 cents), expiring on 30

September 2025

Indirect:

1,502,000 Fully paid ordinary shares

396,132 PABO Listed options, exercisable

at $0.024 (2.4 cents), expiring 5 August

2023

66,022 PABOA Listed options, exercisable

at $0.04 (4 cents), expiring 15 December

2023

Nature of change

Take up of entitlements in the fully

Example: on-market trade, off-market trade, exercise of options,

underwritten pro-ratanon-renounceable

issue of securities under dividend reinvestment plan, participation in

Rights Issue Offer.

buy-back

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract

N/A

Nature of interest

N/A

Name of registered holder

N/A

(if issued securities)

  • See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 3

For personal use only

Appendix 3Y

Change of Director's Interest Notice

Date of change

N/A

No. and class of securities to which interest

N/A

related prior to change

Note: Details are only required for a contract in relation to which

the interest has changed

Interest acquired

N/A

Interest disposed

N/A

Value/Consideration

N/A

Note: If consideration is non-cash, provide details and an estimated

valuation

Interest after change

N/A

Part 3 - +Closed period

Were the interests in the securities or contracts

No

detailed above traded during a +closed period

where prior written clearance was required?

If so, was prior written clearance provided to

N/A

allow the trade to proceed during this period?

If prior written clearance was provided, on what

N/A

date was this provided?

+ See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011

Appendix 3Y Change of Director's Interest Notice

Appendix 3Y

Rule 3.19A.2

For personal use only

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity

Patrys Limited

ABN

97 123 055 363

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for

the director for the purposes of section 205G of the Corporations Act.

Name of Director

John Read

Date of last notice

23 December 2020

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest

Direct and Indirect

Nature of indirect interest

(including r g stered holder)

-

Suzannah Read - 1,031,522 ordinary

Note: Provide details of the circumstances giving rise to the relevant

shares and 11,760 PABOA Listed

interest.

-

options

Harrison Read - 1,031,545 ordinary

shares and 11,767 PABOA Listed

-

options

Linda Greenhow - 158,085 ordinary

shares and

6,949

PABOA Listed

-

options

Cannington Corporation Pty Ltd -

8,130,240 ordinary

shares, 396,132

PABO Listed options and 357,373

The

PABOA Listed options

Director has the ability to influence

the voting and disposal of these shares and

options.

Date of change

6 December 2021

+ See chapter 19 for defined terms.

Appendix 3Y Page 1

01/01/2011

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Patrys Limited published this content on 06 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 December 2021 08:41:02 UTC.


© Publicnow 2021
All news about PATRYS LIMITED
06/14Patrys Identifies New Mechanism of Action for Anti-Cancer Antibody
MT
06/03Patrys Secures Grant Funding to Develop Brain Cancer Drug
MT
04/27PATRYS : Appendix 4C - Quarterly - 31 March 2022
PU
04/14PATRYS : Application for quotation of securities - PAB
PU
03/23NEW RESEARCH : Scientists determine structure of a DNA damage ‘First Responder' prot..
PU
02/27Patrys Limited Announces Stable Cell Line for Production of PAT-DX3
CI
02/24PATRYS : Appendix 4D - Half Year Accounts - 31 December 2021
PU
02/24Patrys Limited Reports Earnings Results for the Half Year Ended December 31, 2021
CI
02/07PATRYS : Application for quotation of securities - PAB
PU
02/07PATRYS : ADC Deals Making Headlines
PU
More news
Financials
Sales 2021 1,34 M 0,93 M 0,93 M
Net income 2021 -4,06 M -2,82 M -2,82 M
Net cash 2021 10,9 M 7,59 M 7,59 M
P/E ratio 2021 -22,2x
Yield 2021 -
Capitalization 45,2 M 31,4 M 31,4 M
EV / Sales 2020 11,5x
EV / Sales 2021 67,8x
Nbr of Employees 10
Free-Float 70,9%
Chart PATRYS LIMITED
Duration : Period :
Patrys Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PATRYS LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Managers and Directors
James A. Campbell Chief Executive Officer, MD & Director
John Douglas Read Non-Executive Chairman
Valentina Dubljevic Vice President-Scientific & Clinical Development
Michael J. Stork Deputy Chairman & Non-Executive Director
Suzy Jones Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
PATRYS LIMITED-40.54%31
MODERNA, INC.-43.20%57 385
IQVIA HOLDINGS INC.-24.22%40 468
LONZA GROUP AG-32.67%39 851
SEAGEN INC.16.00%33 010
CELLTRION, INC.-13.38%18 371